2Ridker PM,Rifai N,Rose L,et al.Compairson of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J].N Engl J Med,2002,347:1557.
3Verma S,Li SH,Badiwada MV,et al.Endothelin antagonism and interleukin-6 inhibition the proatherogenic effects of C-reactive protein[J].Circulation,2002,105:1890.
4Ruygrok PN,de Jaegeve PT,Van Dombury RT,et al.Clinical outcoml 10 years after attempted Percutaneous transluminal coronary angioplasty in 856 Patients[J].J AM coll cardiol,1996,27:1669-1677.
5Wilson SH,Berger PB,Mathew V,et al.Immediate and late outcomes after direct sternt implantation without tallon predilation[J].J Am coll Cardiol,2000,35:937-943.
6Ravkilde J,Nissen H,Mickley H,et al.Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris[J].Am Heart J,1994,127:13-20.
7Harrington RA.Cardiac enzyme elevation after percutaneous coronary intervention:myonecrosis the coronary microcirculation and mortalily[J].J Am coll Cardiol,2000,35:1142-1144.
8Serruys PW,De Feyter P,Macaya C,et al.Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention:a vandomized controlled trial[J].Jama,2002,287:3215-3222.
9Nissen SE.High-dose statins in acute coronary syndromes:not just lipid levels[J].JAMA,2004,292:365.
